
NYSEHealthcareMedical - Diagnostics & Research
Latest quote
$258.28
−$0.81 · -0.31%
Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.
Previous close
$258.28
−$0.81 · -0.31%
Regular session · ET · Market data may be delayed.
Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.
Day range
Current $258.28
52-week range
Current $258.28
Regular session · ET · Market data may be delayed.
GoAI Score
Buy
Valuation
89
Deep Value
Sentiment
68
Bullish
Risk
17
Low Risk
Momentum
46
Neutral
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.
Day range
Current $258.28
52-week range
Current $258.28
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 11.04B USD | 9.87B USD | 9.25B USD | 9.88B USD | 10.79B USD |
| Cost of goods sold | 7.37B USD | 6.63B USD | 6.2B USD | 6.45B USD | 6.58B USD |
| Gross profit | 3.67B USD | 3.24B USD | 3.07B USD | 3.43B USD | 4.21B USD |
| Selling, general, and administrative | 1.97B USD | 1.77B USD | 1.62B USD | 1.87B USD | 1.73B USD |
| Operating expenses | 2.11B USD | 1.9B USD | 1.81B USD | 2.01B USD | 1.83B USD |
| Interest income | 13M USD | 25M USD | 11M USD | 10M USD | 1M USD |
| Interest expense | 277M USD | 226M USD | 163M USD | 148M USD | 152M USD |
| Depreciation and amortization | 570M USD | 493M USD | 439M USD | 437M USD | 408M USD |
| Operating income | 1.56B USD | 1.35B USD | 1.26B USD | 1.43B USD | 2.38B USD |
| Net income | 992M USD | 871M USD | 854M USD | 946M USD | 2B USD |
Company facts updated Nov 22, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Average target
$256.17
0.82% downsideCash distributions grouped by calendar year; partial years are marked.
$3.15
2025 complete year+30.2% since 2021
2026 partial: $3.38
$2.42
2,021
$2.60
2,022
$2.79
2,023
$2.96
2,024
$3.15
2,025
$3.38
2,026*
* Partial calendar year in the available dividend history.
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
DividendUpcoming | Jan 12, 2027 | $0.86Quarterly | Jan 12, 2027 | Jan 27, 2027 |
Dividend | Oct 6, 2026 | $0.86Quarterly | Oct 6, 2026 | Oct 21, 2026 |
Dividend | Jul 8, 2026 | $0.86Quarterly | Jul 8, 2026 | Jul 22, 2026 |
Dividend | Apr 6, 2026 | $0.86Quarterly | Apr 6, 2026 | Apr 20, 2026 |
Dividend | Jan 13, 2026 | $0.80Quarterly | Jan 13, 2026 | Jan 28, 2026 |
Dividend | Oct 3, 2025 | $0.80Quarterly | Oct 3, 2025 | Oct 20, 2025 |
Ex-dividend Jan 12, 2027
$0.86
Quarterly
Record Jan 12, 2027 · Payment Jan 27, 2027
Ex-dividend Oct 6, 2026
$0.86
Quarterly
Record Oct 6, 2026 · Payment Oct 21, 2026
Ex-dividend Jul 8, 2026
$0.86
Quarterly
Record Jul 8, 2026 · Payment Jul 22, 2026
Ex-dividend Apr 6, 2026
$0.86
Quarterly
Record Apr 6, 2026 · Payment Apr 20, 2026
Ex-dividend Jan 13, 2026
$0.80
Quarterly
Record Jan 13, 2026 · Payment Jan 28, 2026
Ex-dividend Oct 3, 2025
$0.80
Quarterly
Record Oct 3, 2025 · Payment Oct 20, 2025
Funds reporting this stock among their holdings, ordered by reported position size.
State Street SPDR S&P 500 ETF1557.T55.57B0.05%119.93T JPY0.09%¥113,700-3.19%
Vanguard S&P 500 ETFVOO738.49M0.04%1T USD0.03%$635.54-3.41%
Vanguard Morningstar Total Stock Market ETFVTI696.42M0.04%689.3B USD0.03%$340.02-3.52%
Vanguard Morningstar Mid-Cap ETFVO593.77M0.27%107.4B USD0.03%$76.25-2.22%
iShares Core S&P 500 ETFIVV383.58M0.05%803.41B USD0.03%$693.71-3.52%
State Street SPDR S&P 500 ETFSPY350.48M0.05%756.38B USD0.09%$689.81-3.64%
Vanguard Morningstar Value ETFVTV267.11M0.10%195.9B USD0.03%$214.22-1.62%
Invesco S&P 500 Equal Weight ETFRSP225.03M0.22%98.53B USD0.20%$207.44-1.98%
State Street SPDR S&P 500 ETF1557.T
Vanguard S&P 500 ETFVOO
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard Morningstar Mid-Cap ETFVO
iShares Core S&P 500 ETFIVV
State Street SPDR S&P 500 ETFSPY
Vanguard Morningstar Value ETFVTV
Invesco S&P 500 Equal Weight ETFRSPAI-generated and delayed market data for informational and educational purposes only. Not investment advice.